A vs ARTV: Which Stock is Better?
Side-by-side comparison of Agilent Technologies Inc and Artiva Biotherapeutics Inc in 2026
A
Agilent Technologies Inc
$114.52
ARTV
Artiva Biotherapeutics Inc
$10.80
Key Metrics Comparison
| Metric | A | ARTV | Winner |
|---|---|---|---|
| Market Cap | $32.65B | $253.10M | A |
| P/E Ratio | 25.51 | N/A | A |
| EPS (TTM) | $4.53 | $N/A | A |
| Revenue Growth | 0.1% | -1.0% | A |
| Gross Margin | 52.3% | 0.0% | A |
Analyze A
Full quant analysis
Analyze ARTV
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is A or ARTV a better investment?
Comparing A and ARTV: Agilent Technologies Inc has a market cap of $32.65B while Artiva Biotherapeutics Inc has $253.10M. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between A and ARTV?
A (Agilent Technologies Inc) and ARTV (Artiva Biotherapeutics Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: A or ARTV?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: A or ARTV?
A has higher revenue growth at 0.1% vs -1.0% for ARTV.
Which company is more profitable: A or ARTV?
Agilent Technologies Inc (A) has higher gross margins at 52.3% compared to 0.0% for ARTV.
Which is the larger company: A or ARTV?
Agilent Technologies Inc (A) is larger with a market cap of $32.65B compared to $253.10M for ARTV.
Should I buy A or ARTV in 2026?
Both A and ARTV have investment merit. A trades at $114.52 while ARTV trades at $10.80. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between A and ARTV stock?
Key differences: Market Cap ($32.65B vs $253.10M), P/E Ratio (25.5x vs N/A), Revenue Growth (0.1% vs -1.0%), Gross Margin (52.3% vs 0.0%).